In practice: RECOVERY Trial
The Randomised Evaluation of coronavirus disease 2019 (COVID-19) Therapy Trial (RECOVERY) has been the largest COVID-19 treatment study conducted. It provided compelling evidence on the safety and efficacy, or lack thereof, of a multitude of therapies postulated to be of benefit to COVID-19 patients...
Автори: | Horby, P, Peto, L, Landray, M |
---|---|
Інші автори: | Sorenson, RA |
Формат: | Book section |
Мова: | English |
Опубліковано: |
Springer
2024
|
Схожі ресурси
Схожі ресурси
-
Establishing COVID-19 trials at scale and pace: experience from the RECOVERY trial
за авторством: Peto, L, та інші
Опубліковано: (2022) -
High-dose corticosteroid therapy in COVID-19: the RECOVERY trial – authors' reply
за авторством: Peto, L, та інші
Опубліковано: (2024) -
Making trials part of good clinical care: lessons from the RECOVERY trial
за авторством: Pessoa-Amorim, G, та інші
Опубліковано: (2021) -
Aspirin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
за авторством: Mafham, M, та інші
Опубліковано: (2021) -
Casirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
за авторством: Landray, M, та інші
Опубліковано: (2022)